91 related articles for article (PubMed ID: 19925050)
1. Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells.
Fung KL; Liang RH; Chan GC
Leuk Lymphoma; 2010 Mar; 51(3):515-22. PubMed ID: 19925050
[TBL] [Abstract][Full Text] [Related]
2. [The anti-tumoral effect of PI3K inhibitor and MEK inhibitor combined with STI571 on chronic myeloid leukemia cells in a bone marrow stromal cell co-culture system].
Jin L; Kato A; Tabe Y
Rinsho Ketsueki; 2006 Oct; 47(10):1364-71. PubMed ID: 17094575
[TBL] [Abstract][Full Text] [Related]
3. [Synergistic inhibitory effect of STI571 in combination with arsenic trioxide on a multidrug-resistant leukemia cell line expressing bcr-abl].
Chen L; Wang JM; Xu XP; Gao L; Fei XH; Lou JW; Huang ZX
Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):535-8. PubMed ID: 15555283
[TBL] [Abstract][Full Text] [Related]
4. Resistance to imatinib of bcr/abl p190 lymphoblastic leukemia cells.
Mishra S; Zhang B; Cunnick JM; Heisterkamp N; Groffen J
Cancer Res; 2006 May; 66(10):5387-93. PubMed ID: 16707466
[TBL] [Abstract][Full Text] [Related]
5. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
[TBL] [Abstract][Full Text] [Related]
7. ALL blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment.
Chiu M; Taurino G; Dander E; Bardelli D; Fallati A; Andreoli R; Bianchi MG; Carubbi C; Pozzi G; Galuppo L; Mirandola P; Rizzari C; Tardito S; Biondi A; D'Amico G; Bussolati O
Blood Adv; 2021 Dec; 5(23):5164-5178. PubMed ID: 34614505
[TBL] [Abstract][Full Text] [Related]
8. Effects of imatinib mesylate in osteoblastogenesis.
Tibullo D; Giallongo C; La Cava P; Berretta S; Stagno F; Chiarenza A; Conticello C; Palumbo GA; Di Raimondo F
Exp Hematol; 2009 Apr; 37(4):461-8. PubMed ID: 19302920
[TBL] [Abstract][Full Text] [Related]
9. [Multidrug resistant gene MDR1 contributes to development of imatinib-resistance in Ph (+) acute lymphoblastic leukemia cell line SUP-BS15RI].
Lin J; Xing HY; Gong YP; Yang X; Guo Y; Shan QQ; Zhou RQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):657-60, 665. PubMed ID: 23230732
[TBL] [Abstract][Full Text] [Related]
10. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture.
Kano Y; Ohnuma T; Okano T; Holland JF
Cancer Res; 1988 Jan; 48(2):351-6. PubMed ID: 3422052
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.
Li X; Miao H; Zhang Y; Li W; Li Z; Zhou Y; Zhao L; Guo Q
Arch Toxicol; 2015 Jan; 89(1):121-36. PubMed ID: 24671465
[TBL] [Abstract][Full Text] [Related]
12. [Effect of bone marrow stromal cells on the apoptotic sensitivity of HL-60 and HL-60/VCR cells].
Liang R; Huang GS; Wang Z; Chen XQ; Bai QX; Zhang WP; Wang JH; Wang WQ; Guo Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):286-92. PubMed ID: 15854294
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia.
Auber ML; Horwitz LJ; Blaauw A; Khorana S; Tucker S; Woods T; Warmuth M; Dicke KA; McCredie KB; Spitzer G
Blood; 1988 Jan; 71(1):166-72. PubMed ID: 2446678
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.
Nguyen TK; Rahmani M; Gao N; Kramer L; Corbin AS; Druker BJ; Dent P; Grant S
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2239-47. PubMed ID: 16609040
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological agents with inherent anti-autophagic activity improve the cytotoxicity of imatinib.
Crowley LC; O'Donovan TR; Nyhan MJ; McKenna SL
Oncol Rep; 2013 Jun; 29(6):2261-8. PubMed ID: 23564048
[TBL] [Abstract][Full Text] [Related]
16. Imatinib-loaded polyelectrolyte microcapsules for sustained targeting of BCR-ABL+ leukemia stem cells.
Palamà IE; Leporatti S; de Luca E; Di Renzo N; Maffia M; Gambacorti-Passerini C; Rinaldi R; Gigli G; Cingolani R; Coluccia AM
Nanomedicine (Lond); 2010 Apr; 5(3):419-31. PubMed ID: 20394535
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.
Martins AS; Mackintosh C; Martín DH; Campos M; Hernández T; Ordóñez JL; de Alava E
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3532-40. PubMed ID: 16740780
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of K562 cell lines resistant to STI571 and a preliminary biological study].
Gao L; Wang JM; Xu XP; Chen L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):584-9. PubMed ID: 15498115
[TBL] [Abstract][Full Text] [Related]
19. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ
J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487
[TBL] [Abstract][Full Text] [Related]
20. Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy.
Saitoh T; Matsushima T; Iriuchishima H; Yamane A; Irisawa H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H
Leuk Lymphoma; 2006 Dec; 47(12):2667-9. PubMed ID: 17169818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
